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In doubtful cases and in patients with high perio-
perative risk, a laparoscopy has been performed and in
most cases the lesser sac was opened and inspected.
With this procedure,wewere able to decrease thenumber
of unnecessary laparotomies significantly. In times of
cost efficiency and limited resources new diagnostic
measures have to be tested against non-invasive cheaper
methods. As stated also by the authors, these new
methods have to be evaluated .against conventional
investigations in prospective comparative studies.
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OPERATIVE VS NON-OPERATIVE MANAGEMENT
IN STERILE NECROTIZING PANCREATITIS
ABSTRACT
Rau, B., Pralle, U., Uhl, W., Schoenberg, M.H. and Beger, H.G. (1995) Management
of sterile necrosis in instances of severe acute pancreatitis. Journal of The American
College of Surgeons, 181." 279-288.
Background: The clinical management of sterile pancreatic necrosis is still a matter of
debate. In this study we analyzed the clinical course and outcome of patients with sterile
necrotizing pancreatitis treated surgically versus nonsurgically.
Study Design: Between May 1982 and December 1993, 249 patients with necrotizing
pancreatitis (NP) entered this study, of which 172 (69 percent) had intraoperatively or
fine needle aspiration-proven sterile NP. One hundred seven of 172 patients underwent
surgery (S group) with necrosectomy and continuous postoperative closed lavage and
65 of 172 were treated by nonsurgical means (NS group).
Results: Median Ranson and admission APACHE II scores were 4.7 (range, 1 to 10)
and 11 (range, 1 to 29) in the S group, significantly higher than those in the NS group
with 3.0 (range, 0 to 6) (p=0.022) and 8 (range, 1 to 23) (p=0.036). After 48 hours of
intensive care treatment, APACHE II scores persisted at 10.5 (range, 1 to 29) in the S
group and decreased to 6 (range, 0 to 15) (p=0.013) in the NS patients. Median C-
reactive protein (CRP) levels on admission were 179 mglL and 68.5 mg/L (p=0.023),
respectively. Within 72 hours, 61 (94 percent) of 65 NS-managed patients responded to
intensive care therapy, whereas organ complications persisted or increased and thus led
to surgery in the S group. Mortality rates were 13.1 percent in the surgically treated
patients and 6.2 percent in the nonsurgically treated patients (p=NS).
Conclusions: Most patients with limited and sterile pancreatic necrosis respond to
intensive care treatment. Indication for surgery in sterile NP should be based onHPB INTERNATIONAL 189
persisting or advancing organ complications despite intensive care therapy. APACHE
II scores and adraission CRP levels represent a helpful tool in decision making for
surgical or nonsurgical management of NP. J. Am. Coll. Surg., 1995, 181: 279-288.
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PAPERDISCUSSION
Indications for surgical intervention in patients with
acute necrotizing pancreatitis are continuing to evolve.
Despite almost universal acceptance ofthe necessity for
surgical debridement in infected pancreatic necrosis,
whether or not surgical necrosectomy offers any ad-
vantage to patients with sterile pancreatic necrosis has
been problematic.
In this thoughtful and comprehensive retrospective
analysis of a single institutional experience over an 11
year period, Dr. Rau and her colleagues have presented
us with the indications for surgery in sterile pancreatic
necrosis(SPN) as currently practiced in Ulm. Of 172
patients with SPN initially treated with intensive
medical therapy, 107 were selected for surgery within 72
hours either because of "persisting organ failure" (72
patients), or "abdominal complications (for example;
ileus, peritonitis, choledochal stenosis, etc.)" (32
patients). In keeping with developing knowledge, the
62% current surgical intervention rate from this center
represents adownward modification from their original
recommendation for global debridement ofpancreatic
necrosis 1. The surgical approach consisted of
necrosectomy and lesser sac lavage, performed in
almost all cases within 7 days of the onset of illness.
Sixty-five other patients with SPN who demonstrated
improvement within the 72 hour period did not undergo
surgery. Unfortunately, significant differences between
the surgical and non-surgical groups in APACHE II
scores (11 vs. 8), and in the extent of pancreatic necrosis
(42 patients > 30% necrosis vs. 22 patients > 30%
necrosis), precluded using the non-operative group as
controls. Observed adverse increases in the surgical
group with regard to mortality (13% vs. 6%), days of
ICU treatment (16.5 vs. 7.0), days of hospitalization
(44.5 vs. 20.0), and complications such as secondary
abscess (29 vs. 1), and sepsis (45 vs. 5), were attributed by
the authors to "...the higher severity ofthe disease...".
However, it is equally likely that the post-operative
pancreatic infections which developed in 54% of
the 72 surgical patients with SPN could have caused
the excessive mortality and morbidity observed in the
surgical group. Indeed, it is more than likely than not
that the observed secondary pancreatic infections
occurred as a consequence of exposing sterile injured
tissues to ambient flora by the process of surgical
debridment and prolonged drainage. In a collected
group of 191 patients with SPN undergoing debridement
(Table 1), 30% developed post-operative infections in the
residual pancreatic tissue (2-4). Moreover, the high
overall mortality rate of 18% (36/191) was made even
worse by the realization that when surgically-induced
infection did occur, the mortality rate was 63% (36/
57). While we cannot know with absolute certainty
that these post-operative pancreatic infections were
surgically induced, infections are far less likely to
occur in patients with comparable extent of necrosis
treated without surgery (4-8). Other complications
reported by Rau et al., such as the development of
intestinalfistulas in27% ofcases and the necessity for re-
operation in 39% ofpatients, are directly attributable to
surgical intervention and are less disputable.
Dismissing for themoment the possibility that surgical
debridement of SPN is actually harmful, is there any
persuasive evidence that operative intervention in these
cases is beneficial? Since the tacit assumption underlying
Professor Beger’s surgical approach to SPN is that
debridement will result in a reduction in mortality, it is
reasonable to ask whether the surgical approach does in
fact improve mortality risk in these patients. Moreover,
because themajor stated surgical indication in their series
was persistent organ failure, is there any evidence that
surgical debridement improves the course of organ
insufficiency in patients with SPN? It is axiomatic that
meaningful evaluation of any putative therapeutic
approach requires comparison to an appropriate control
Table 1 Risk of latrogenic Pancreatic Infection Following
Surgical Debridement of Sterile Pancreatic Necrosis
Number of Pancreatic Mortality
Patients Infections due to
Infection
Smadja & Bismuth 38 14(37%) 9(24%)
Widdison et al.* 130 37(28%) 22(17%)
Uomo et al. 23 6(26%) 5(22%)
Totals (avg) 191 57(30%) 36(19%)
*Collected Series190 HPB INTERNATIONAL
group. Since a population of unoperated patients with
equally severeSPNwas notably absentfrom their report,
we are forced to turn to natural history information in
order to evaluate their approach tomanagement.
In collected series of 287 unoperated patients with
SPN (4-8), directly comparable to the Ulm series in
that the average extent ofpancreatic necrosis was 54%,
single or multiple organ failure existed in 39%, and
equivalent indicators of severity were present, the
overall mortality rate was found to be 9.7% (Table 2).
When this mortality rate derived from these
prospective studies is compared to the retrospective
13% surgical mortality reported by Rau et al., no
advantage to surgical intervention in comparable
patients is apparent. Moreover, there is little available
persuasive evidence that surgical intervention
favorably affects either the incidence or the course of
organ failure. Smadja and Bismuth were unable to
detect any beneficial effects of necrosectomy on pre-
existing organ failure in thier patients, and in fact
concluded that surgical intervention exacerbated
organ insufficiency2. Similar negative conclusions
regarding surgical amelioration of organ failure have
been reached by other workers3’4. From a theoretic
standpoint, if organ failure were due to the remote
effects of circulating noxious substances released by
pancreatic necrosis, then removal of the necrotic
tissues should result in a relatively rapid reversal of
organ dysfunction, given the reasonable supposition
that the half-lives of these serum substances should be
short. Yetmany studies have failed to demonstrate any
conclusive benefit to organ failure following with
debridement of SPN. Since continuously elevated
APACHE II scores usually reflect persisting organ
failure, and the average post operative APACHE II
scores in the Ulm patients remained relatively
constant for at least 7 days following surgery, it is even
difficult to demonstrate any favorable organ effects to
debridement in their cases.
Ifthere is no unequivocal survival advantage to surgery
in comparable patients, no demonstrable amelioration in
existing organ failure, and ifthe potential exists for actual
harm in the form of intestinal fistula formation and
surgically induced infection, it is not clear that the case
has beenmade forprogrammatic surgical debridement in
patients with SPN.
Even though the overwhelming majority of patients
with SPN do not appear to benefit from necrosectomy, it
remains possible that smaller sub-groups of patients
might gain from surgical intervention. In our experience,
the only patients for whom debridement of SPN is of
unquestioned value are those who develop abdominal
pain and hyperamylasemia resulting from attempts at
oral feeding after 4-6 weeks of non-operative therapy.
This clinical configuration occurs in 5-7% ofcases, and is
usually due to necrosis-induced changes in the pancreatic
ductal system. Accordingly, the principal issue of
contention in this debate is not whether surgical
debridement should be done inanypatientwithSPN, but
ratherhow frequently it is necessary.
It would seem that additional validation is required
before we can accept the Ulm proposals that the
majority of patients with SPN require operative
intervention, or that the necessity for surgery can be
predicted by the duration of organ failure, specific
serum levels of C-reactive protein, or APACHE II
thresholds. Moreover, the increasing amount of
natural history data generated from comparable non-
operated patients, has placed the burden of proof
placed squarelyupon the shoulders ofthose advocating
surgery. It is becoming increasingly clear to many that
in the near future surgical debridement of sterile
necrotizing pancreatitis will become the exception
rather than the rule.
Table 2 Non-Operative Management of Sterile Pancreatic Necrosis
Extent of Organ
Patients Necros& Failure
Year (U) (A VG%) (U)
Bradley et al. 1991 & FF* 40 58 19
Guillames et al. 1992" 27 NS NS
Andersson et al. 1994 59 NS NS
Uhl et al. 1995" 15 35 10
Uomo eta/. 1996" 146 55 49
Severity
14A
NS
NS
7A
>3R(89%)
Mortality
(%)
10.0
7.4
10.0
0
9.5
Total 287 54% 39%
* Prospective
NS Not Stated
A Apache II Points
R Ranson Signs
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JEJUNUM OR STOMACH FOR THE PANCREATIC
ANASTOMOSIS AFTER PANCREATICODUODENECTOMY
ABSTRACT
Yeo, C.J., Cameron, J.L., Maher, M.M., Sauter, P.K., Zahurak, M.L., Talamini, M.A.,
Lillernoe, K.D. and Pitt, H.A. (1995) A prospective randomized trial of pancreatico-
gastrostomy versus pancreaticojejunostorny after pancreaticoduodenectomy. Annals of
Surgery; 222: 580-592.
Objective: The authors hypothesized that pancreaticogastrostomy is safer than pan-
creaticojejunostomy after pancreaticoduodenectomy and less likely to be associated with
a postoperative pancreatic fistula.
Summary Background Data: Pancreatic fistula is a leading cause of morbidity and
mortality after pancreaticoduodenectomy, occurring in 10% to 20% of patients.
Nonrandomized reports have suggested that pancreaticogastrostomy is less likely than
pancreaticojejunostomy to be associated with postoperative complications.
Methods: Between May 1993 and January 1995, the findings for 145 patients were
analyzed in this prospective trial at The Johns Hopkins Hospital. After giving their
appropriate preoperative informed consent, patients were randomly assigned to pan-
creaticogastrostomy or pancreaticojejunostomy after completion of the pancreatico-
duodenal resection. All pancreatic anastomoses were performed in two layers without
pancreatic duct stents and with closed suction drainage. Pancreatic fistula was defined as
drainage of greater than 50 mL of amylase-rich fluid on or after postoperative day 10.
Results: The pancreaticogastrostomy (n=73) and pancreaticojejunostomy (n=72)
groups were comparable with regard to multiple parameters, including demographics,
medical history, preoperative laboratory values, and intraoperative factors, such as
operative time, blood transfusions, pancreatic texture, length of pancreatic remnant
mobilized, and pancreatic duct diameter. The overall incidence of pancreatic fistula
after pancreaticoduodenectomy was 11.7% (171145). The incidence of pancreatic fis-
tula was similar for the pancreaticogastrostomy (12.3%) and pancreaticojejunostomy
(11.1%) groups. Pancreatisc fistula was associated with a significant prolongation of
postoperative hospital stay (36+5 vs. 15+1 days) (p<0.001). Factors significantly
increasing the risk of pancreatic fistula by univariate logistic regression analysis